2D High-Density Multi-Electrode Array Electrophysiology Platform

HEALTH AND HUMAN SERVICES, DEPARTMENT OF — FOOD AND DRUG ADMINISTRATIO·MD*·RFP·Federal

Scope

The purpose of this amendment is to provide clarification regarding the Government�s final acceptance timeframe. No further questions will be addressed regarding this solicitation. The solicitation closing date and time will not be extended. **************************************************************************************************************************************************** The U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grants Services (OAGS), is issuing this combined synopsis/solicitation for the acquisition of a 2D High-Density Multi-Electrode Array (MEA) Electrophysiology Platform, including required hardware, software, accessories, initial consumables, installation, system verification, calibration, training, warranty coverage, and preventative maintenance option periods. This solicitation is issued as a Request for Quotation (RFQ) for…

Documents, amendments and submission instructions are on the agency's own posting.